Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Neurocrine Biosciences reacquires rights to novel MS treatment

July 13, 1999

Novel gabapentin analogues with anticonvulsant and/or analgesic effects

July 13, 1999

Nastech completes phase III testing of intranasal scopolamine

July 13, 1999

High-dose tirilazad mesilate assessed in women with aneurysmal subarachnoid hemorrhage

July 13, 1999

U.S. DOD funds study of HupA as neuroprotective agent

July 13, 1999

Allelix characterizes first-generation NGF receptor antagonist with antiallodynic properties

July 12, 1999

Johns Hopkins team identifies unusually promising new treatment for ALS

July 12, 1999

Mallinckrodt and SmithKline Beecham sign copromotion agreement for ADHD drug

July 12, 1999

FDA advisory committee to consider OTC status for Flexeril

July 9, 1999

Abaperidone undergoes extensive efficacy and safety testing at Ferrer

July 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...